Attenuated, streptomycin-dependent salmonella typhi oral vaccine: Potentialdeleterious effects of lyophilization

Myron M. Levine, Richard B. Hornick, Merrill J. Snyder, William Woodward, Robert H Gilman, Joseph P. Libonati

Research output: Contribution to journalArticle

Abstract

Four studies were done with streptomycin-dependent Salmonella ty phi as an oral, attenuated vaccine. Studies 1 and 3 employed freshly harvested vaccine, whereas studies 2 and 4 involved lyophilized vaccine. Five to eight doses (3 X 1010—1011 organisms/dose) were given; oral streptomycin (1.0 g) was administered concomitantly in studies 2 and 3, with only two of the doses of vaccine in study 1, and was not given in study 4. No adverse reactions were encountered in 179 vaccinated men, and 94% of the men excreted the vaccine. In challenge studies (which included the control groups) with 105 virulent S. typhi organisms (Quailes strain), the fresh vaccine was highly protective (66%—78% efficacy), while lyophilized vaccine gave no clinical protection. Fresh vaccine also interfered significantly with intestinal proliferation of virulent S. typhi only 17% of the vaccinees excreted organisms as compared with 75% of the controls. Studies of protection in mice showed no difference between immunogen content of the fresh and the lyophilized vaccines. Field trials with streptomycin-dependent, oral typhoid vaccine must await development of a lyophilized product that will retain the protective properties of the vaccine.

Original languageEnglish (US)
Pages (from-to)424-429
Number of pages6
JournalJournal of Infectious Diseases
Volume133
Issue number4
DOIs
StatePublished - 1976
Externally publishedYes

Fingerprint

Salmonella typhi
Freeze Drying
Streptomycin
Vaccines
Typhoid-Paratyphoid Vaccines
Attenuated Vaccines
Salmonella
Control Groups

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Attenuated, streptomycin-dependent salmonella typhi oral vaccine : Potentialdeleterious effects of lyophilization. / Levine, Myron M.; Hornick, Richard B.; Snyder, Merrill J.; Woodward, William; Gilman, Robert H; Libonati, Joseph P.

In: Journal of Infectious Diseases, Vol. 133, No. 4, 1976, p. 424-429.

Research output: Contribution to journalArticle

Levine, Myron M. ; Hornick, Richard B. ; Snyder, Merrill J. ; Woodward, William ; Gilman, Robert H ; Libonati, Joseph P. / Attenuated, streptomycin-dependent salmonella typhi oral vaccine : Potentialdeleterious effects of lyophilization. In: Journal of Infectious Diseases. 1976 ; Vol. 133, No. 4. pp. 424-429.
@article{be963d22ea2048d788eee57a78e9c355,
title = "Attenuated, streptomycin-dependent salmonella typhi oral vaccine: Potentialdeleterious effects of lyophilization",
abstract = "Four studies were done with streptomycin-dependent Salmonella ty phi as an oral, attenuated vaccine. Studies 1 and 3 employed freshly harvested vaccine, whereas studies 2 and 4 involved lyophilized vaccine. Five to eight doses (3 X 1010—1011 organisms/dose) were given; oral streptomycin (1.0 g) was administered concomitantly in studies 2 and 3, with only two of the doses of vaccine in study 1, and was not given in study 4. No adverse reactions were encountered in 179 vaccinated men, and 94{\%} of the men excreted the vaccine. In challenge studies (which included the control groups) with 105 virulent S. typhi organisms (Quailes strain), the fresh vaccine was highly protective (66{\%}—78{\%} efficacy), while lyophilized vaccine gave no clinical protection. Fresh vaccine also interfered significantly with intestinal proliferation of virulent S. typhi only 17{\%} of the vaccinees excreted organisms as compared with 75{\%} of the controls. Studies of protection in mice showed no difference between immunogen content of the fresh and the lyophilized vaccines. Field trials with streptomycin-dependent, oral typhoid vaccine must await development of a lyophilized product that will retain the protective properties of the vaccine.",
author = "Levine, {Myron M.} and Hornick, {Richard B.} and Snyder, {Merrill J.} and William Woodward and Gilman, {Robert H} and Libonati, {Joseph P.}",
year = "1976",
doi = "10.1093/infdis/133.4.424",
language = "English (US)",
volume = "133",
pages = "424--429",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Attenuated, streptomycin-dependent salmonella typhi oral vaccine

T2 - Potentialdeleterious effects of lyophilization

AU - Levine, Myron M.

AU - Hornick, Richard B.

AU - Snyder, Merrill J.

AU - Woodward, William

AU - Gilman, Robert H

AU - Libonati, Joseph P.

PY - 1976

Y1 - 1976

N2 - Four studies were done with streptomycin-dependent Salmonella ty phi as an oral, attenuated vaccine. Studies 1 and 3 employed freshly harvested vaccine, whereas studies 2 and 4 involved lyophilized vaccine. Five to eight doses (3 X 1010—1011 organisms/dose) were given; oral streptomycin (1.0 g) was administered concomitantly in studies 2 and 3, with only two of the doses of vaccine in study 1, and was not given in study 4. No adverse reactions were encountered in 179 vaccinated men, and 94% of the men excreted the vaccine. In challenge studies (which included the control groups) with 105 virulent S. typhi organisms (Quailes strain), the fresh vaccine was highly protective (66%—78% efficacy), while lyophilized vaccine gave no clinical protection. Fresh vaccine also interfered significantly with intestinal proliferation of virulent S. typhi only 17% of the vaccinees excreted organisms as compared with 75% of the controls. Studies of protection in mice showed no difference between immunogen content of the fresh and the lyophilized vaccines. Field trials with streptomycin-dependent, oral typhoid vaccine must await development of a lyophilized product that will retain the protective properties of the vaccine.

AB - Four studies were done with streptomycin-dependent Salmonella ty phi as an oral, attenuated vaccine. Studies 1 and 3 employed freshly harvested vaccine, whereas studies 2 and 4 involved lyophilized vaccine. Five to eight doses (3 X 1010—1011 organisms/dose) were given; oral streptomycin (1.0 g) was administered concomitantly in studies 2 and 3, with only two of the doses of vaccine in study 1, and was not given in study 4. No adverse reactions were encountered in 179 vaccinated men, and 94% of the men excreted the vaccine. In challenge studies (which included the control groups) with 105 virulent S. typhi organisms (Quailes strain), the fresh vaccine was highly protective (66%—78% efficacy), while lyophilized vaccine gave no clinical protection. Fresh vaccine also interfered significantly with intestinal proliferation of virulent S. typhi only 17% of the vaccinees excreted organisms as compared with 75% of the controls. Studies of protection in mice showed no difference between immunogen content of the fresh and the lyophilized vaccines. Field trials with streptomycin-dependent, oral typhoid vaccine must await development of a lyophilized product that will retain the protective properties of the vaccine.

UR - http://www.scopus.com/inward/record.url?scp=0017261919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017261919&partnerID=8YFLogxK

U2 - 10.1093/infdis/133.4.424

DO - 10.1093/infdis/133.4.424

M3 - Article

C2 - 1262709

AN - SCOPUS:0017261919

VL - 133

SP - 424

EP - 429

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -